NantHealth, Inc. (NASDAQ:NH) Sees Significant Growth in Short Interest

NantHealth, Inc. (NASDAQ:NH – Get Rating) saw a large increase in short interest in the month of February. As of February 28th, there was short interest totalling 51,000 shares, an increase of 17.5% from the February 13th total of 43,400 shares. Based on an average daily trading volume, of 104,100 shares, the short-interest ratio is currently 0.5 days. Approximately 2.0% of the shares of the company are short sold.

Institutional Investors Weigh In On NantHealth

A number of large investors have recently made changes to their positions in the business. Goldman Sachs Group Inc. bought a new stake in shares of NantHealth in the 2nd quarter worth approximately $36,000. Millennium Management LLC purchased a new position in shares of NantHealth in the 2nd quarter valued at approximately $110,000. Atria Wealth Solutions Inc. lifted its stake in shares of NantHealth by 117.7% in the 2nd quarter. Atria Wealth Solutions Inc. now owns 491,942 shares of the company’s stock valued at $205,000 after purchasing an additional 265,949 shares during the period. Finally, Hartline Investment Corp purchased a new position in shares of NantHealth in the 2nd quarter valued at approximately $65,000. 4.50% of the stock is currently owned by institutional investors.

NantHealth Price Performance

NH opened at $2.25 on Monday. The stock’s 50 day simple moving average is $3.25 and its 200 day simple moving average is $1.62. NantHealth has a 1 year low of $1.57 and a 1 year high of $15.30. The firm has a market cap of $17.35 million, a price-to-earnings ratio of -0.29 and a beta of 1.86.

Analyst Ratings Changes

Separately, StockNews.com assumed coverage on NantHealth in a report on Monday. They issued a “hold” rating on the stock.

NantHealth Company Profile

(Get Rating)

NantHealth, Inc is an evidence-based, personalized healthcare company, which engages in the provision of treatment for critical diseases such as cancer. The firm empowers treatment decisions, improves patient outcomes, validates treatment options, enables high-quality care, lowers costs, ensures appropriate reimbursement, and streamlines implementation and deployment.